Most major global financial assets have reacted as largely expected to Donald Trump's victory in the U.S. presidential ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

Bitcoin (BTC-USD) is set to rise 8.3% on a weekly basis, as the cryptocurrency continues to see a meteoric rise after Donald ...

On November 22, renowned (and infamous) investor Jim Cramer revealed his bullish stance — now, some are worried that BTC ...

Famed investor dubs Bitcoin a winner as he picks it over MSTR. Citron recently revealed a short position in MicroStrategy ...

MicroStrategy, a leading business intelligence firm, announced the completion of its 0% convertible senior notes offering worth $3B, which is due in 2029. The money raised will be used to purchase ...

MicroStrategy Incorporated (NASDAQ:MSTR) has experienced an extraordinary 674% increase in its stock price year-to-date in 2024, a rally driven by its massive Bitcoin holdings and the cryptocurrency’s ...

Major equity averages were mixed Thursday, with tech behemoths Nvidia (NVDA) and Google parent Alphabet (GOOG) weighing on ...

Citron Research’s Andrew Left believes the run in shares of MicroStrategy Inc (NASDAQ:MSTR) is not going to end well in the ...

Bitcoin spot ETFs, led by BlackRock's iShares Bitcoin Trust, have pulled fresh institutional money into the game. Add Bitcoin ...

Well, this is a Bitcoin surprise. Michael Saylor, the Executive Chairman of MicroStrategy, has lost his voting control over ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) and Zymeworks (NASDAQ:ZYME) announced Thursday the FDA approval of their jointly developed bispecific antibody Ziihera as a late-line treatment for certain adults ...